A new agreement extension was singed between Clatterbridge Centre for Oncology NHS Foundation Trust (CCO) and IMS MAXIMS. Based on this agreement, a new, web-based, electronic patient records system is going to be installed in the leading cancer center. The agreement took place as a result to an appraisal in which Clatterbridge Centre for Oncology NHS Foundation Trust selected IMS from other available alternatives.
High-leveled information systems are important to CCO. The center is an internationally-renowned organization for oncology that provides help to a number of 7,500 new patients every year. The center aids its patients by offering them a wide range of complex and condensed healthcare service. Moreover, it helps visiting medical and nursing members to offer cancer services at several general hospitals including Merseyside, Cheshire and the Isle of Man. After the appraisal was finished, a three-year extension to the ongoing contract was agreed. This means that the partnership will be going on until 2015. Upon the new extension, immediate upgrade will take place of all IMS MAXIMS applications currently installed at CCO. This will allow staff and patients to take advantages from the high-leveled, updated, web based applications.
"IMS MAXIMS was helpful and constructive throughout the appraisal, which was designed to determine our precise needs and direction of travel in the years ahead. They were keen to meet our specific requirements and we are now on a very solid footing for delivering a whole range of benefits." said Tom Poulter, CCO's Head of Information Management and Technology. IMS MAXIMS has a proven track record and good reputation of on-time delivery and achieving the objectives of the National Program for IT (NPfIT) and the Clinical 5. Based on the new agreement, several steps are to be carried out including an upgrade of the existing patient administration system (PAS) by introducing WebPAS. The system will allow improved user-friendly features, and integrates with MAXIMS clinical applications.
Moreover, MAXIMS web application will be upgraded. This represents a move towards a complete web-based system. "This means we won't have to install additional client software every time we upgrade. As there are 600 computers, that makes a big difference to our system administration and technical overheads - saving time and money because it frees IT staff to do other things. It will also bring greater flexibility, allowing healthcare professionals to access MAXIMS wherever they are, using a secure web portal." commented Poulter. The IMS MAXIMS agreement will definitely reduce waiting times by enhancing radiotherapy workflow. This is going to be achieved by introducing an electronic action sheet for oncologists. Poulter said "The paper forms used at present can take 1.8 days to go through the system. If a consultant running a clinic at the Royal Liverpool Hospital fills in a treatment form on a Friday it can be Monday before it is dealt with at our main hospital. The new system will be instantaneous, having a direct impact on patient waiting times,"
The center has a promising plan, a one that aims to exceed the Clinical 5 to achieve a higher Clinical 5+. This will stop completely any need to have paper-based records to be transferred throughout the system. Moreover, all records are going to be available for members when they need them. IMS is taking a major role in managing these tasks by offering the electronic document and records management system (EDRMS) integration. Poulter commented on the extension of the agreement saying "An early decision to extend the contract with IMS has enabled us to benefit from a range of system enhancements on a cost-neutral basis and we look forward to working closely with IMS to implement the Clinical 5+,"
Shane Tickell, IMS MAXIMS CEO, said "We have a long and very strong relationship with CCO and have proven our ability to provide tailor-made solutions for its unique needs. The Trust's confidence in the IMS MAXIMS solutions has been demonstrated by the fact that it has made such an early decision to extend our contract. It shows great faith in our ability to stay ahead of the competition and to deliver the world-class clinical and administrative systems needed by a leading oncology centre."